Perspective Therapeutics

Performance

About Perspective Therapeutics

Perspective Therapeutics is a radiopharmaceutical company focused on image-guided, targeted alpha-particle therapies for cancer. The company develops Pb-212–based radiotherapies to deliver high-energy alpha radiation directly to tumor cells using high-affinity targeting peptides, aiming to treat neuroendocrine tumors, melanoma, and other solid tumors. It also offers an image-guided theranostics approach to confirm tumor expression and distribution prior to treatment, supporting patient selection and outcome optimization.